Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Effectiveness and Safety Confirmation Between FASTSEAL® Bioabsorbable Vascular Access Closure System and Perclose® ProGlide Suture-Mediated Closure System; Randomized, Comparative Study

NCT01597570 is registered in ClinicalTrials.gov with Taewoong Medical Co., Ltd. as lead sponsor.

NCT NCT01597570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01597570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Effectiveness and Safety Confirmation Between FASTSEAL® Bioabsorbable Vascular Access Closure System and Perclose® ProGlide Suture-Mediated Closure System; Randomized, Comparative Study
Lead sponsor
Taewoong Medical Co., Ltd.
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2012
Completion date
December 10, 2012
Enrollment
52 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

the patients who needed hemostasis at the puncture site of common femoral artety(cfa) caused by femoral angiogram or intervention after the catheter removal